In a keynote talk during GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11, 2025, Neville Sanjana, PhD, Core Faculty Member at the New York Genome Center and Associate Professor at New York University, spoke about current work in his lab focused on CRISPR screens.
Research in Sanjana’s lab is focused on developing technologies for massively parallel forward genetic screens and genome engineering, as well as using these tools to interrogate how specific genetic variants influence disease risk. The laboratory pursues this goal by combining complementary approaches from bioengineering, genomics, neuroscience, cancer biology, and systems biology.
In his presentation entitled: “Pinpointing causal noncoding variants using massively-parallel single-cell CRISPR screens,” Sanjana discusses the large question his research is trying to answer: “How can we efficiently identify which regions or genome drive disease?”
The entire virtual summit is available to watch free on demand: bit.ly/CRISPR25
The post New CRISPRs to Probe the Human Noncoding Genome with Neville Sanjana appeared first on GEN – Genetic Engineering and Biotechnology News.
